Estrella Immunopharma, Inc.ESLANASDAQ
Loading
Research and development spending
5Y CAGR
+86.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
22.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.25M | +59.9% |
| 2024 | $6.41M | +56.0% |
| 2023 | $4.11M | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $1.39M | +203.8% |
| 2020 | $457231.00 | - |